FDA Clearance Tracker · P170011-S030
Impella RP with SmartAssist System
Last checked: Nov 20, 2026Latest source record: Jun 28, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jun 28, 2021
Approved
Time to decision
180 days
Received Dec 30, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P170011-S030
- Device name
- Impella RP with SmartAssist System
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- Dec 30, 2020
- Decided
- Jun 28, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P170011
Device type
- Device class
- Class III
- Regulation
- 21 CFR 870.4360
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a design modification to the Impella RP System involving the addition of a fiber-optic pressure sensor.
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.